サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1313428

リアルタイムPCR市場：製品（装置、試薬・消耗品、ソフトウェア・サービス）、用途（臨床、法医学、調査）、エンドユーザー別-2023～2030年の世界予測

Real-time PCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Forensics, Research), End Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
リアルタイムPCR市場：製品（装置、試薬・消耗品、ソフトウェア・サービス）、用途（臨床、法医学、調査）、エンドユーザー別-2023～2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

リアルタイムPCRの世界市場は、2023年に34億4,599万米ドル、CAGR 9.67%で大幅な成長が予測され、2030年には驚異的な66億761万米ドルに達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のリアルタイムPCR市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.リアルタイムPCRの世界市場規模および予測は？

2.予測期間中、世界のリアルタイムPCR市場を形成するCOVID-19の阻害要因と影響は？

3.リアルタイムPCRの世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.リアルタイムPCRの世界市場における競争戦略は？

5.リアルタイムPCRの世界市場における技術動向と規制の枠組みは？

6.リアルタイムPCRの世界市場における主要ベンダーの市場シェアは？

7.リアルタイムPCRの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 感染症と遺伝性疾患の蔓延
      • 疾患診断のためのバイオマーカープロファイリングの迅速な利用
      • 病気の原因となる微生物の早期診断と臨床診断検査の利用の増加
    • 抑制要因
      • リアルタイムPCRに関連するデバイスのコストが高い
    • 機会
      • コンパクトでポータブルなラボオンチップPCRデバイスの継続的な技術統合と開発
      • 植物由来からゲノムベースの創薬への急速な移行
    • 課題
      • リアルタイムPCR手法の技術的限界と熟練した専門家の不足
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 リアルタイムPCR市場：製品別

  • イントロダクション
  • 装置
  • 試薬と消耗品
  • ソフトウェアとサービス

第7章 リアルタイムPCR市場：用途別

  • イントロダクション
  • 臨床
  • 法医学
  • 研究

第8章 リアルタイムPCR市場：エンドユーザー別

  • イントロダクション
  • 臨床研究機関
  • 法医学研究所
  • 病院と診断センター
  • 製薬およびバイオテクノロジー企業
  • 研究および学術機関

第9章 南北アメリカのリアルタイムPCR市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のリアルタイムPCR市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのリアルタイムPCR市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. REAL-TIME PCR MARKET RESEARCH PROCESS
  • FIGURE 2. REAL-TIME PCR MARKET SIZE, 2022 VS 2030
  • FIGURE 3. REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. REAL-TIME PCR MARKET SIZE, BY END USERS, 2022 VS 2030 (%)
  • FIGURE 7. REAL-TIME PCR MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. REAL-TIME PCR MARKET DYNAMICS
  • FIGURE 9. REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. REAL-TIME PCR MARKET SIZE, BY END USERS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. REAL-TIME PCR MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. REAL-TIME PCR MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. REAL-TIME PCR MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 13. REAL-TIME PCR MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. REAL-TIME PCR MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. REAL-TIME PCR MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. REAL-TIME PCR MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 145. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 146. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 147. REAL-TIME PCR MARKET LICENSE & PRICING
目次
Product Code: MRR-0D217D5AEDCE

The Global Real-time PCR Market is forecasted to grow significantly, with a projected USD 3,445.99 million in 2023 at a CAGR of 9.67% and expected to reach a staggering USD 6,607.61 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Real-time PCR Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Real-time PCR Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services. The Reagents & Consumables is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical, Forensics, and Research. The Clinical is projected to witness significant market share during forecast period.

Based on End Users, market is studied across Clinical Research Organizations, Forensic Laboratories, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Research Laboratories & Academic Institutes. The Forensic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Real-time PCR Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Real-time PCR Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Real-time PCR Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Real-time PCR Market?

4. What is the competitive strategic window for opportunities in the Global Real-time PCR Market?

5. What are the technology trends and regulatory frameworks in the Global Real-time PCR Market?

6. What is the market share of the leading vendors in the Global Real-time PCR Market?

7. What modes and strategic moves are considered suitable for entering the Global Real-time PCR Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Real-time PCR Market, by Product, 2022 vs 2030
  • 4.3. Real-time PCR Market, by Application, 2022 vs 2030
  • 4.4. Real-time PCR Market, by End Users, 2022 vs 2030
  • 4.5. Real-time PCR Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of infectious diseases and genetic disorders
      • 5.1.1.2. Rapid utilization of biomarker profiling for disease diagnostics
      • 5.1.1.3. Rising early diagnosis of disease-causing microbes and the use of clinical diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. High device costs associated with real-time PCR
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological integration and development of compact, portable, and lab-on-chip PCR devices
      • 5.1.3.2. Rapid shift from plant-derived to genome-based drug discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of real-time PCR techniques and lack of skilled professionals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Real-time PCR Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. Real-time PCR Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical
  • 7.3. Forensics
  • 7.4. Research

8. Real-time PCR Market, by End Users

  • 8.1. Introduction
  • 8.2. Clinical Research Organizations
  • 8.3. Forensic Laboratories
  • 8.4. Hospitals & Diagnostic Centers
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Research Laboratories & Academic Institutes

9. Americas Real-time PCR Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Real-time PCR Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Real-time PCR Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing